|
SEARCH
|
Research Papers by Author
Arnold
Impact of PCV2 vaccination for controlling Porcine Circovirus Associated Disease in a wean to finish production system - IPVS 2008 (view pdf)
Impact of Ingelvac CircoFLEX® on PCV2 and porcine circovirus associated disease in
a wean-to-finish production system - AASV 2008 (view pdf)
Baysinger
Assessing the impact of maternally derived immunity on active immunization of pigs against PCV2 - IPVS 2010 (view pdf)
Profile and agreement of dam and piglet PCV2 IFA titers - IPVS 2010 (view pdf)
Visual-only evaluation of lung lesions as an alternative to palpation at necropsy - IPVS 2010 (view pdf)
Assessing the impact of maternally derived immunity on active immunization of pigs against PCV2 - AASV 2010 (view pdf)
Assessing the impact of maternally derived immunity on active immunization of pigs against PCV2 - Leman 2009 (view pdf)
Bretey
Performance benefits resulting from vaccination with Ingelvac CircoFLEX and/or Ingelvac PRRS MLV - AASV 2010 (view pdf)
Performance benefits resulting from vaccination with Ingelvac CircoFLEX and/or Ingelvac PRRS MLV - BI Pre-AASV Health Seminar 2010 (view pdf)
Performance benefits resulting from vaccination with Ingelvac CircoFLEX and/or Ingelvac PRRS MLV - Leman 2009 (view pdf)
Efficacy of Ingelvac CircoFLEX® in a herd with subclinical PCVAD - Leman 2008 (view pdf)
Christmas
Injection site histologic lesions induced by commercial PCV2 piglet vaccines - Leman 2007 (view pdf)
Cline
A case report on the dynamics of PCVAD in a PCV2-vaccinated herd over time - Leman 2008 (view pdf)
An economic analysis of vaccinating pigs with Ingelvac CircoFLEX® to control uncomplicated clinical PCVAD - IPVS 2008 (view pdf)
Efficacy of Ingelvac® CircoFLEX™ in pigs vaccinated at 3 or 6 weeks of age in a PRRS and Mycoplasma hyopneumoniae-negative production system - Leman 2007 (view pdf)
Cunningham
Seroprevalence of PCV2 in Canadian swine herds - IPVS 2008 (view pdf)
Desrosiers
The impact of seroconversion following vaccination on the efficacy of PCV2 vaccination - IPVS 2008 (view pdf)
Results obtained with a novel PCV2 vaccine to protect multiple ages of pigs against PCVAD - Leman 2007 (view pdf)
Diaz
Differential diagnosis of wasting and respiratory disease in PCV2 vaccinated populations of pigs - Leman 2009 (view pdf)
PCV2 infection dynamics under field conditions - Leman 2008 (view pdf)
Correlation of serum PCV2 quantitative PCR test results to tissue IHC lesion scores and mortality rates - Leman 2007 (view pdf)
PCV2 infection dynamics in vaccinated versus non-vaccinated groups of pigs from 5 farms - Leman 2007 (view pdf)
Edler
Efficacy of PCV2 vaccination of pigs, dams, or both on pig performance - Leman 2008 (view pdf)
Eichmeyer
Efficacy evaluation of a mixed Mycoplasma hyopneumoniae bacterin and a porcine circovirus type 2 vaccine - AASV 2009 (view pdf)
Efficacy evaluation of a Mycoplasma hyopneumoniae bacterin in a mixture with a porcine circovirus type 2 vaccine - Leman 2008 (view pdf)
Efficacy evaluation of a Mycoplasma hyopneumoniae bacterin in a mixture with a porcine circovirus type 2 vaccine - IPVS 2008 (view pdf)
Fangman
Willingness to approach behavior and feed disappearance of weaned pigs following vaccination with Mycoplasma hyopneumoniae vaccines - Leman 2008 (view pdf)
Willingness to approach behavior and feed disappearance of weaned pigs following vaccination with mycoplasma vaccines - IPVS 2008 (view pdf)
Feldmann
Effects of porcine circovirus type 2 (PCV2) vaccination on mortality and average daily gain - AASV 2008 (view pdf)
Genzow
Rapid onset of protection of two weeks for a novel one dose mycoplasma vaccine - Leman 2008 (view pdf)
Rapid onset of protection of two weeks for a novel one dose mycoplasma vaccine - IPVS 2008 (view pdf)
The effect of vaccination against PRRSV on quantitative PCV2 PCR results - Leman 2007 (view pdf)
Gillespie
Comparative performance of barns of pigs vaccinated or not vaccinated with a one-shot PCV2 vaccine - IPVS 2008 (view pdf)
Gonzalez
Use of cross-sectional serum quantitative PCR for profiling PCV2 infection dynamics - Leman 2007 (view pdf)
Grosse Liesner
Efficacy of Ingelvac CircoFLEX® in face of maternal antibodies in a field trial in France - Leman 2008 (view pdf)
Haas
Pork quality implications of PCV2 vaccines under normal conditions of use - IPVS 2008 (view pdf)
Holck
Correlation between viral load and performance in PCV2 vaccinated or non-vaccinated pigs - Leman 2009 (view pdf)
Johnson
Test characteristics when verifying Mycoplasma hyopneumoniae status in expected negative herds - Leman 2009 (view pdf)
A comparison of cross-sectional quantitative PCV2 PCR vs. individual animal quantitative PCV2 PCR and associated necropsy findings in 4 cases - Leman 2008 (view pdf)
Jones
PRRS control: Has it changed post PCV2? - BI Pre-AASV Health Seminar 2010 (view pdf)
Controlling PCV2 and co-infections to reduce the impact of PCVAD in growing pigs - Leman 2007 (view pdf)
King
Biologic and economic benefits of controlling subclinical PCVAD with vaccination - AASV 2008 (view pdf)
Kolb
Performance of conventional health pigs vaccinated with Ingelvac MycoFLEX® or Suvaxyn® RespiFend - Leman 2008 (view pdf)
A laboratory evaluation of the comparative injection site tissue reactivity of PCV2 vaccines - IPVS 2008 (view pdf)
Comparative safety of PCV2 vaccines under field conditions - AASV 2008 (view pdf)
Comparative performance of barns of pigs vaccinated with Ingelvac CircoFLEX or other PCV2 vaccines - Leman 2007 (view pdf)
Lewandowski
Comparison and economic evaluation of two PCV2 vaccination programs used in France - Leman 2009 (view pdf)
Lowe
The quagmire of Enzootic Pneumonia: A view from the trenches - BI Pre-AASV Health Seminar 2010 (view pdf)
Maass
Impact of PCV2 viremia in vaccinated and non-vaccinated pigs - Leman 2009 (view pdf)
McDowell
Diagnostic investigation into a reproductive failure associated with porcine parvovirus and porcine circovirus coinfection - AASV 2009 (view pdf)
Mette
Effect of PCV2 vaccination on co-infections with porcine reproductive and respiratory syndrome virus and mycoplasma hyorhinis - IPVS 2008 (view pdf)
Miyashita
Efficacy of a novel one-shot PCV2 vaccine under Japanese field conditions - IPVS 2008 (view pdf)
Orveillon
Effect of PCV2 vaccination on growth performance in a subclinically affected herd - Leman 2008 (view pdf)
Piontkowski
Ingelvac MycoFLEX® provides at least 26 weeks duration of immunity against M. hyopneumoniae - Leman 2008 (view pdf)
Ramirez
Vaccination against PCV2 versus tissue homogenate in finishing phase - Leman 2008 (view pdf)
Ritzmann
Efficacy of a novel one-shot PCV2 vaccine in a multi-site production system in Southern Germany - IPVS 2008 (view pdf)
Lack of interference with maternal immunity and reduction of viremia in PCV2 vaccinated pigs - IPVS 2008 (view pdf)
Schwartz
Diagnosing clinical disease and subclinical infections in a vaccinated population - BI Pre-AASV Health Seminar 2010 (view pdf)
Survey of PMWS impact on Brazilian swine companies - IPVS 2008 (view pdf)
Strait
Update on methods for detecting of pathogenic mycoplasma species - AASV 2011 (view pdf)
Taylor
Visual-only evaluation of lung lesions as an alternative to palpation at necropsy - AASV 2010 (view pdf)
Verbeck
Field evaluation of Ingelvac CircoFLEX® on growth performance of pigs in a subclinical PCVAD herd - AASV 2009 (view pdf)
Wilt
An investigation into increased finishing mortality associated with uncomplicated PCV Type 2 infection: A case report - Leman 2007 (view pdf)
Young
Performance of Ingelvac CircoFLEX® vaccinated pigs in a subclinical PCVAD herd - IPVS 2008 (view pdf)
Suvaxyn and RespiFend are registered trademarks of Fort Dodge Animal Health.
